Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity

Although the use of tenofovir alafenamide (TAF), a new prodrug of tenofovir, was safe and efficacious in clinical trials, real-world data from multimorbid individuals are scarce. Among 10 persons living with HIV with previous tenofovir disoproxil fumarate–induced nephrotoxicity, renal function remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Walti, Laura N, Steinrücken, Julia, Rauch, Andri, Wandeler, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262111/
https://www.ncbi.nlm.nih.gov/pubmed/30515426
http://dx.doi.org/10.1093/ofid/ofy275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262111/
https://www.ncbi.nlm.nih.gov/pubmed/30515426
http://dx.doi.org/10.1093/ofid/ofy275

Ejemplares similares